From left to right: Milica Radisic, Rick Lu and Claudia dos Santos March 27, 2024 By Betty Zou University of Toronto researchers have created a unique heart-on-a-chip model that is helping untangle the causes of COVID-19-induced heart inflammation and uncover...
(Photo credit: Julia Soudat) March 18, 2024 By Betty Zou Canada's ability to respond rapidly to emerging infectious diseases is taking a step forward with a $9.9-million investment from the Ontario government to support critical research infrastructure updates to the...
From left to right: Robert Kozak, Sharmistha Mishra and Darrell Tan March 7, 2024 By Betty Zou A new University of Toronto study has found that mpox virus DNA can be found in different parts of the body for up to four weeks after symptom onset. The study, led by...
Samantha Ismail led a study looking for antibodies against SARS-CoV-2 in human milk. January 23, 2024 By Betty Zou The COVID-19 pandemic was an especially harrowing time for pregnant people and new parents. The uncertainties about how the new coronavirus could affect...
Subha Dahal (left) and Alice Zhabokritsky December 1, 2023 By Betty Zou Over four decades after the start of the AIDS epidemic, researchers in the Emerging and Pandemic Infections Consortium are reshaping approaches to target the human immunodeficiency virus (HIV)...
A new study from a team of EPIC members has uncovered the biological reasons underlying sex differences in COVID-19 outcomes and is offering a promising new strategy to prevent illness. Early on during the pandemic, clinicians quickly noticed that males were more likely than females to be hospitalized or admitted to the ICU or to die from COVID-19 despite having similar infection rates. This pattern held true across all age groups and in countries around the world. The research, conducted in mice and published in the journal iScience, points to the ACE2 protein as a key contributor to differences in COVID-19 outcomes between males and females.
From left to right: Mario Ostrowski, Haissi Cui and Landon Edgar July 27, 2023 By Betty Zou and Mayuri Punithan Two teams of researchers at the University of Toronto have partnered with Moderna Canada to advance new mRNA-based therapies for HIV and other diseases. The...
Mosquito-transmitted diseases affect an estimated 347.8 million people annually and are responsible for nearly 450,000 deaths each year, making them one of the most dangerous animals in the world. Despite their devastating impact, research on the mosquito has lagged behind that of other model organisms, in part due to the lack of appropriate tools and resources. Kathryn Rozen-Gagnon is trying to change that. Read more about how she is integrating diverse fields to study the interplay between mosquito-borne viruses and their mosquito and human hosts.
The University of Toronto has received $35 million in critical research infrastructure funding from the federal government to revitalize the Toronto High Containment Facility (THCF), an investment that will support a planned $85-million transformation of the facility into the largest academic high-containment research centre in Canada. With significantly increased capacity for research and training, the revitalized Toronto High Containment Facility will be able to drive innovation, enhance pandemic preparedness and strengthen Ontario and Canada’s health security.
A team of researchers led by EPIC member Samira Mubareka has characterized a new, highly divergent variant of SARS-CoV-2 in Ontario white-tailed deer. They also found the first evidence of deer-to-human transmission.
Related page →
Link to resource →
Contact us CTA →